Sharda Cropchem Limited Annual Report FY2026

Official PDF · AI Summary · Financial Analysis
Official Annual + Quarterly Filings · AI Business Intelligence
NSE: SHARDACROP
Sector: Chemicals
Industry: Pesticides & Agrochemicals
Source: NSE / BSE
Last Updated: 04 Aug 2026
Business Intelligence Report Verdict
High
Outlook: Positive

Quality Scores

Business Compounding
82/100
Compounder
81/100
Management
80/100
Governance
88/100
Cash Flow
68/100

Latest Quarterly Earnings Summary

No quarterly summary available yet.

AI Summary

Sharda Cropchem operates an asset-light business model focused on the identification and registration of agrochemical formulations and non-agro products globally. The company distinguishes itself by outsourcing manufacturing to third parties, primarily in China, while maintaining control over the distribution and marketing intellectual property (registrations). Over the last decade, the business has demonstrated strong scaling, with sales growing from ₹1,061 Cr in FY15 to over ₹5,000 Cr in TTM terms. While FY24 presented a significant cyclical downturn with margins compressing to 10%, the…

Key Changes in FY2026

The business has evolved from a merchant exporter to a global registration powerhouse, moving up the value chain by securing its own IPs in highly regulated markets like the EU and USA. Over the last decade, Sharda has successfully diversified its product portfolio from basic insecticides to a balanced mix of herbicides and fungicides, while also maintaining a non-agro segment. The geographic footprint has expanded significantly, reducing dependence on any single region, though Europe remains a cornerstone. Digital transformation and supply chain optimization have become recent focuses to manage the volatility of Chinese raw material sourcing. The evolution score is high, reflecting the successful transition from a trading-focused entity to a regulatory-moat-driven business.

Management Commentary

Management demonstrates high execution capability in navigating complex global regulatory environments, evidenced by a vast and growing portfolio of registrations. The communication is transparent, provided through detailed quarterly earnings calls and investor presentations. The leadership has successfully transitioned the company through various global cycles, including supply chain disruptions and volatile raw material pricing. However, the heavy reliance on Chinese sourcing remains a strategic dependency that management continues to manage rather than eliminate. Executive compensation appears aligned with performance, and the promoter holding remains stable at a high 74.82%.

Financial Highlights

The business has delivered a 10-year sales CAGR of 16% and a 5-year profit CAGR of 24%, indicating efficient scaling. However, financial performance is characterized by significant margin volatility, as seen in the drop from 23% OPM in FY17 to 10% in FY24 before recovering. Return on Capital Employed (ROCE) has historically been superior, often exceeding 25%, though it dipped to 4% during the FY24 industry-wide destocking phase. The asset-light nature allows for high capital efficiency, but the high debtor days (166 days) suggest that working capital management is a persistent challenge. Net profit growth has generally tracked revenue growth over a long horizon, reflecting stable pricing power despite generic competition.

Major Opportunities

  • Virtually debt-free balance sheet
  • Asset-light business model focusing on registrations
  • Diversified geographic presence (Europe, NA, LATAM)

Major Risks

  • High debtor days (166 days) indicating working capital pressure
  • Vulnerability to global agrochemical price cycles
  • Heavy reliance on Chinese sourcing for active ingredients

About This Annual Report

The Sharda Cropchem Limited FY2026 Annual Report is the company's flagship annual disclosure, filed with NSE / BSE. It covers the full-year business review, management discussion & analysis (MD&A), audited financial statements, director's report, corporate governance report, auditor's report, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This page consolidates the official PDF and an AI-generated summary so investors can quickly grasp what changed vs. prior years — sales growth, margin trend, cash flow quality, capex, dividends and management outlook — without having to read the entire filing.

Why Use AI?

  • Summarises hundreds of pages into a focused executive briefing
  • Identifies year-on-year key changes automatically
  • Extracts management commentary and tone
  • Highlights top risks and opportunities
  • Compares business evolution vs. earlier years
  • Answers your questions in plain English via Ask AI

Frequently Asked Questions

Related Research

AI Top Insights — Premium

Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.